Skip to main content
Cardinal Health reaches distribution deal with GenePOC

Canadian molecular diagnostics firm GenePOC and Cardinal Health have reached an agreement allowing Cardinal to exclusively distribute GenePOC's portable, qPCR-based molecular diagnostics instrument, revogene, and related assays in the US. The revogene instrument, designed to run point-of-care tests, received clearance from the FDA earlier this month for use with the GenePOC GBS LB assay in the detection of group B streptococcus.

Full Story: